Navigation Links
Novus Scientific and Singapore Association of Plastic Surgeons (SAPS) Host the Inaugural Event of 'SOFTISSUE - The Issue of Soft Tissue,' Featuring James J. Chao, M.D., FACS, Professor of Plastic Surgery and Orthopedic Surgery, University of Califor
Date:11/3/2010

SINGAPORE, Nov. 3, 2010 /PRNewswire/ -- Singapore company Novus Scientific Pte. Ltd today announced the successful hosting of Asia's 1st "SOFTISSUE – The Issue of Soft Tissue" educational series, together with the Singapore Association of Plastic Surgeons (SAPS) on 1st November 2010.

This inaugural event featured James J. Chao, M.D., FACS, who spoke on "Technological Innovations in Plastic Surgery," which focused on the latest advances in breast reconstruction & fat grafting. Dr. Chao is currently Professor of Plastic Surgery and Orthopedic Surgery at the University of California, San Diego (UCSD) Medical Centre. Attendees consisted of Plastic & General Surgeons from Singapore and the region, as well as select government agencies and members of the health media. The venue was at the Novus Restaurant, housed in the historical National Museum of Singapore.

"I am honored to be invited as the 1st speaker of SOFTISSUE, as it provides not only a great platform for U.S. Plastic Surgeons such as myself to interact and share clinical best practices with surgeons of SAPS, but also an opportunity to collaborate on future clinical studies, which may bring tremendous benefits to patients worldwide," said James J. Chao, M.D., FACS, Professor of Plastic Surgery & Professor of Orthopedic Surgery, (UCSD).

"Novus Scientific is a proud supporter of the 1st SOFTISSUE, together with SAPS, which brings together the top Plastic, Aesthetic and Reconstructive Surgeons in Singapore and the U.S. for an educational meeting of minds," said Thomas Engstrom, CEO & President of Novus Scientific. "We plan to bring SOFTISSUE to the U.S. as well as to Europe and beyond in the years to come."

Novus Scientific is currently supporting a clinical study on TRAM Flap donor site reinforcement using TIGR® Matrix Surgical Mesh. Asia's first patient was enrolled on 21st October 2010 at the National University Hospital Singapore. Link http://bit.ly/btihfu

TIGR® Matrix is the World's 1st Long-Term Resorbable Synthetic Mesh. U.S. FDA cleared TIGR® Matrix Surgical Mesh for use in reinforcement of soft tissues where weakness exists in February 2010.

About Novus Scientific

Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable synthetic medical devices. Global HQ is in Singapore while European Headquarters and the core R&D function are in Uppsala, Sweden. The company's roots are Swedish as all the founders of Novus Scientific are previous owners / senior managers / members of the soft tissue-engineering project within Uppsala-based, Radi Medical Systems AB (now owned by St. Jude Medical Inc). The US Division, Novus Scientific, Inc. is headquartered near Boston, one of the world's foremost medical research cities. From this hub, Novus Scientific, Inc. will distribute TIGR® Matrix Surgical Mesh throughout the United States.

TIGR® is a trademark of Novus Scientific Pte. Ltd

Media contact: Tac-Whei Ong (tacwhei.ong@novusscientific.com) - tel: +65 9179 6661


'/>"/>
SOURCE Novus Scientific Pte. Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
2. Novus Scientific Announces the Sales Launch for TIGR™ Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
5. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
6. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
7. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
8. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
9. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
10. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
11. Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
Breaking Medicine Technology:
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
Breaking Medicine News(10 mins):